The CDC panel discusses the J&J Covid vaccine after a uncommon blood clot drawback
[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]
An advisory panel from the Centers for Disease Control and Prevention is holding an emergency meeting Friday to discuss Johnson & Johnson’s Covid-19 vaccine and its use after six women developed a rare but potentially life-threatening bleeding disorder called the one left dead.
A positive recommendation from the CDC Advisory Committee on Immunization Practices could pave the way for US regulators to lift the recommended hiatus for the use of the J&J shot earlier this weekend.
The CDC panel decided to postpone a decision on the vaccine last week while officials continued to investigate cases of six women who developed cerebral sinus thrombosis (CVST) within about two weeks of receiving the shot.
Earlier this week, J&J announced that it would restart its vaccine rollout in Europe after regulators there backed the single vaccine by recommending adding a warning to the label. The European Medicines Agency has examined all available evidence, including reports from the United States.